Speaker Profile
M.S., Director and Head of Clinical & Business Development, Geisinger National Precision Health
Biography
Erica Ramos develops and implements strategic partnerships and ventures to extend the Geisinger MyCode model on the national scene and accelerate the transition from research to clinical programs, both at Geisinger and beyond. She is also the 2018 President of the National Society of Genetic Counselors, the leading professional organization for genetic counselors more than 3500 members strong. Prior to joining Geisinger, Ms. Ramos spent 11 years in patient care, ranging from prenatal to cancer and adult, then joined Illumina’s Clinical Services Laboratory in 2012, where she managed the clinical group that implemented interpretation and reporting processes for clinical whole genome sequencing (cWGS). As an Associate Director of Market Development at Illumina, she then focused on advancing the use of whole genome sequencing in clinical care, with a focus on predictive genomics and population health. She also tweets from @ERamosSD about genomics and genetic counseling, music, travel and other interests.
Session Abstract – PMWC 2019 Silicon Valley
Session Synopsis: A growing number of hospitals are offering predictive medicine by screening entire populations or specific subgroups for genetic information in order to target interventions for common disorders such as heart disease, diabetes, and cancer. Such screening can help identify groups at risk so that primary- or secondary-prevention efforts can be initiated.
